Skip to Content

VentriPoint Diagnostics Ltd VPTDF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

VentriPoint Diagnostics Ltd is a Canada based medical device company. It is primarily engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure and normal hearts. It sells its products in Canada and internationally.

Contact
2 Sheppard Avenue East, Suite 605
Toronto, ON, M2N 5Y7, Canada
T +1 416 848-4156
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2019
Stock Type
Employees